Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1b Study of Andecaliximab in Participants With Spinal Cord Injury at Risk of Developing Heterotopic Ossification

NCT07024407 is registered in ClinicalTrials.gov with Ashibio Inc as lead sponsor.

NCT NCT07024407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07024407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1b Study of Andecaliximab in Participants With Spinal Cord Injury at Risk of Developing Heterotopic Ossification
Lead sponsor
Ashibio Inc
Phase
Phase 1/2
Overall status
Recruiting
Start date
May 14, 2025
Completion date
January 31, 2026
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heterotopic ossification (ho)